COO Stock Recent News
COO LATEST HEADLINES
Explore how The Cooper Companies' (COO) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Cooper Companies beats on Q3 earnings with 15% EPS growth, but revenue weakness and a trimmed 2025 outlook send shares tumbling.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
The stock of medical device specialist Cooper Companies (COO 0.13%) was hurting on the second-to-last trading day of the week. It sank to a 13% loss on the day, following the publication of the company's latest quarterly earnings release.
The Cooper Companies, Inc. (NASDAQ:COO ) Q3 2025 Earnings Conference Call August 27, 2025 5:00 PM ET Company Participants Albert G. White - President, CEO & Non-Independent Director Brian G.
The Cooper Companies (COO) came out with quarterly earnings of $1.1 per share, beating the Zacks Consensus Estimate of $1.07 per share. This compares to earnings of $0.96 per share a year ago.
SAN RAMON, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal third quarter ended July 31, 2025.
Though many of the biggest names in the investing world have already reported earnings in this most recent cycle, some lesser-known firms remain yet to report. Besides being a key way for investors to monitor companies' progress in achieving their strategic goals, these reports are often a catalyst for share price shifts.
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either The Cooper Companies (COO) or Merit Medical (MMSI). But which of these two stocks is more attractive to value investors?